BOT 14.3% 40.0¢ botanix pharmaceuticals ltd

Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-625

  1. 295 Posts.
    lightbulb Created with Sketch. 325
    correct, same with the table (thanks aburbe) from the ACZONE trial for secondary: trial 006 inflammatory lesion ACZONE = 56% Vehicle = 49%
    trial 007 ACZONE = 54% Vehicle = 48%
    Non-inflammatory ACZONE 45% Vehicle 39% & 46% and 41% respectively!!
    https://hotcopper.com.au/data/attachments/1790/1790997-276ebf6ca9f4e0e022b395886976291d.jpg
    https://hotcopper.com.au/threads/ann-botanix-announces-btx-1503-data-and-progression-to-phase-3.5026520/page-306?post_id=41022719
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
40.0¢
Change
0.050(14.3%)
Mkt cap ! $724.0M
Open High Low Value Volume
35.5¢ 40.0¢ 35.5¢ $6.075M 15.87M

Buyers (Bids)

No. Vol. Price($)
5 287187 39.5¢
 

Sellers (Offers)

Price($) Vol. No.
40.0¢ 1920397 33
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.